(Q34985471)

English

HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL). (English)

1 reference

Europe PubMed Central

5 August 2017

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Hans-Georg Rammensee

8

object named as

Hans-Georg Rammensee

1 reference

Europe PubMed Central

5 August 2017

Stefan Stevanović

9

object named as

Stefan Stevanovic

1 reference

Europe PubMed Central

5 August 2017

author name string

Daniel J Kowalewski

1

1 reference

Europe PubMed Central

5 August 2017

Heiko Schuster

2

1 reference

Europe PubMed Central

5 August 2017

Linus Backert

3

1 reference

Europe PubMed Central

5 August 2017

Claudia Berlin

4

1 reference

Europe PubMed Central

5 August 2017

Stefan Kahn

5

1 reference

Europe PubMed Central

5 August 2017

Lothar Kanz

6

1 reference

Europe PubMed Central

5 August 2017

Helmut R Salih

7

1 reference

Europe PubMed Central

5 August 2017

Juliane Sarah Stickel

10

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

29 December 2014

1 reference

Europe PubMed Central

5 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

5 August 2017

112

1 reference

Europe PubMed Central

5 August 2017

E166-75

1 reference

Europe PubMed Central

5 August 2017

2

1 reference

Europe PubMed Central

5 August 2017

Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Database of T cell-defined human tumor antigens: the 2013 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Nivolumab plus ipilimumab in advanced melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Cancer genome landscapes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Biochemical large-scale identification of MHC class I ligands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Cancer immunotherapy comes of age

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

A new era in anticancer peptide vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

CD4 cells can be more efficient at tumor rejection than CD8 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Towards patient-specific tumor antigen selection for vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

KEGG: kyoto encyclopedia of genes and genomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

8 July 2018

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

Breakthrough of the year 2013. Cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

Combination checkpoint blockade--taking melanoma immunotherapy to the next level.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

"License to kill" reflects joint action of CD4 and CD8 T cells

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

Semi-supervised learning for peptide identification from shotgun proteomics datasets.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1416389112

21 January 2018

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299203

26 October 2018

Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25548167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25548167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissection of T-cell Antigen Specificity in Human Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25548167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/25548167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25548167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.1416389112

1 reference

Europe PubMed Central

5 August 2017

2015PNAS..112E.166K

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34985471&oldid=1550099961"